197 385

Cited 0 times in

Cited 0 times in

Modified reverse shock index predicts early outcomes of heart failure with reduced ejection fraction

Authors
 Oh, Gyu Chul  ;  An, Seokyung  ;  Lee, Hae-Young  ;  Cho, Hyun-Jai  ;  Jeon, Eun-Seok  ;  Lee, Sang Eun  ;  Kim, Jae-Joong  ;  Kang, Seok Min  ;  Hwang, Kyung-Kuk  ;  Cho, Myeong-Chan  ;  Chae, Shung Chull  ;  Choi, Dong-Ju  ;  Yoo, Byung-Su  ;  Kim, Kye Hun  ;  Park, Sue K.  ;  Baek, Sang Hong 
Citation
 ESC HEART FAILURE, Vol.9(5) : 3232-3240, 2022-10 
Journal Title
ESC HEART FAILURE
ISSN
 2055-5822 
Issue Date
2022-10
Keywords
Heart failure ; Blood pressure ; Heart rate ; Mortality
Abstract
Aims Increased blood pressure (BP) and decreased heart rate (HR) are signs of stabilization in patients admitted for acute HF. Changes in BP and HR during admission and their correlation with outcomes were assessed in hospitalized patients with heart failure (HF) with reduced ejection fraction (HFrEF). Methods A novel modified reverse shock index (mRSI), defined as the ratio between changes in systolic BP and HR during admission, was devised, and its prognostic value in the early outcomes of acute HF was assessed using the Korean Acute HF registry. Results Among 2697 patients with HFrEF (mean age 65.8 +/- 14.9 years, 60.6% males), patients with mRSI >= 1.25 at discharge were significantly younger and were more likely to have de novo HF. An mRSI >= 1.25 was associated with a significantly lower incidence of 60-day and 180-day all-cause mortality [hazard ratio (HR) 0.49, 95% confidence interval (CI) 0.31-0.77; HR 0.62, 95% CI 0.45-0.85, respectively), compared with 1 <= mRSI < 1.25 (all P < 0.001). Conversely, an mRSI < 0.75 was associated with a significantly higher incidence of 60-day and 180-day all-cause mortality (adjusted HR 2.08, 95% CI 1.19-3.62; HR 2.24, 95% CI 1.53-3.27; all P < 0.001). The benefit associated with mRSI >1.25 was consistent in sub-group analyses. The correlation of mRSI and outcomes were also consistent regardless of admission SBP, presence of atrial fibrillation, or use of beta blockers at discharge. Conclusions In patients hospitalized for HFrEF, the mRSI was a significant predictor of early outcomes. The mRSI could be used as a tool to assess patient status and guide physicians in treating patients with HFrEF.
DOI
10.1002/ehf2.14031
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers
Yonsei Authors
Kang, Seok Min(강석민) ORCID logo https://orcid.org/0000-0001-9856-9227
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/194604
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse

Links